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Background: Our objective was to evaluate the comparative effectiveness of intraperitoneally adminis-
tered vitamin E and human amniotic membrane in preventing postoperative intraperitoneal adhesion
formation.
Material and Methods: 75 Wistar-albino rats were separated into 5 groups: Group 1 (control), Group 2
(intraperitoneal olive oil, the diluent of vitamin E), Group 3 (Intraperitoneal vitamin E diluted in olive oil),
Group 4 (Amniotic membrane group) and Group 5 (Amniotic membrane and Intraperitoneal vitamin E
diluted in olive oil). The same experimental method, consisting of cecal abrasion and ligature of the
adjacent parietal peritoneum, was used in all rats to produce adhesions. Relaparotomy was performed on
the 15th postoperative day. intra-abdominal adhesions were scored according to macromorphological
characteristics and adhesion-carrying tissues underwent standard histologic examination. Inﬂammation,
vascularization and ﬁbrosis in granulation sites were graded in all samples. The results were analyzed
using a Mann–Whitney-U test.
Results: In terms of inﬂammation, neovascularization and ﬁbrosis scores obtained by histology and
macromorphologic adhesion scores. There were no signiﬁcant differences between Groups 1 and 2
(p¼ 0.176). The results of Groups 3, 4 and 5 showed a signiﬁcant difference when compared with both
Group 1 and 2 (p¼ 0.001). The difference between Groups 3, 4 and 5 were not signiﬁcant with respect to
these 4 parameters.
Conclusion: Intraperitoneal vitamin E and amniotic membrane treatment were both effective in the
prevention of peritoneal adhesions. The combination of these agents did not produce a synergistic effect.
Easy applicability of the intraperitoneal administration of vitamin E was its major advantage.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Abdominal adhesions are abnormal attachments between
tissues and organs that occur as a result of injury to the peritoneal
surface. The most common cause of intra-abdominal adhesions is
a history of previous abdominal surgery.1 The formation of intra-
abdominal adhesions may result from mechanical peritoneal
damage, intra-abdominal tissue ischemia or the presence of foreign
material.2,3 Postsurgical adhesions severely affect the quality of life,
causing small-bowel obstruction, difﬁcult reoperative surgery,
chronic abdominal and pelvic pain and female infertility.4–6 SeveralDaire: 7 Bakirkoy, Istanbul,
.
ciates Ltd. Published by Elsevier Lttreatment strategies have been evaluated to prevent or minimize
the occurrence of adhesions. These include improving surgical
techniques, using pharmacologic interventions targeted at the
inﬂammatory response and ﬁbrin deposition, and using agents that
provide a physical barrier to adhesion formation.7–9
Vitamin E theoretically has interesting biological properties.
In vitro studies have shown that vitamin E has antioxidant, anti-
inﬂammatory, anticoagulant and antiﬁbroblastic effects and
decreases collagen production.10 These properties have led to the
investigation of vitamin E in various studies for the prevention of
adhesions.11,12
The amniotic membrane is a tissue of fetal origin and
composed of three major layers: a single epithelial layer, a thick
basement membrane and an avascular mesenchyme. It contains
basement membrane components, growth factors and proteinase
inhibitors.13,14 Studies indicate that this membrane possessesd. All rights reserved.
Table 1
Scoring system for intraperitoneal adhesions.
Grade Description of adhesive bands Remarks
0 Complete absence of adhesions Unsubstantial adhesions
1 Only one band of adhesions among
visceras or between one viscera and
the abdominal wall
2 Two bands: among visceras or from
viscera to abdominal wall
Substantial adhesions
3 More than two bands: among visceras
or from viscera to the abdominal wall
or all intestine making a mass without
adhesion to the abdominal wall
4 Viscera adhered directly to the abdominal
wall, independent of the number and the
extension of adhesion bands
Fig. 2. Grade 2 neovascularization (HE 40).
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epithelization and wound healing, inhibit inﬂammation and
scarring, and regulate angiogenesis.15–17 The amniotic membrane
has been used in various surgical procedures including treatment
of wounds, reconstruction of conjunctival defects, reconstruction
of the oral cavity and prevention of postoperative adhesions.18–20
In this study we aimed to compare the effects of amniotic
membrane and intraperitoneal vitamin E in the prevention of
peritoneal adhesions.2. Materials and method
This experimental study was conducted in the Department of
Physiology of Istanbul Medical Faculty after approval by the local
ethical committee. Seventy-ﬁve Wistar-Albino rats with weights
ranging between 180 and 220 g were separated into 5 groups
according to treatment:
Group 1 : Adhesion induction
Group 2 : Adhesion induction and intraperitoneal administration
of 5 ml of pure olive oil (diluent of vitamin E)
Group 3 : Adhesion induction and intraperitoneal administration
of 10 mg vitamin E dissolved in 5 ml olive oil.
Group 4 : Adhesion induction and insertion of human amniotic
membrane on the injured site of the cecumFig. 1. Grade 3 inﬂammation (HE 40).Group 5 : Adhesion induction, intraperitoneal administration of
10 mg vitamin E dissolved in 5 ml olive oil and insertion
of human amniotic membrane on the injured site of the
cecum.2.1. Surgical technique
All animals were anesthesized with intramuscular administra-
tion of 50 mg/kg ketamine. Following laparatomy via a 4 cm
midline incision, adhesion formation model described by Hemadeh
et al.21 was used. According to this model, a gauze sponge was
rubbed on the serosa of the cecum until the serosal shine was lost
and punctuate hemorrhagic spots oozing blood were formed.
A drop of absolute alcohol was applied to the punctuate hemor-
rhagic areas of the cecum to further stimulate adhesion formation.
The cecum was then returned to the abdomen. The parietal peri-
toneum neighboring the cecumwas held with a ﬁne hemostat and
a 3/0 silk suture was tied to this area. In Group 1, the abdomenwas
closed after adhesion formation method without any further
treatment. In Group 2, pure olive oil, the diluent of vitamin E, was
sterilized in an autoclave and was given 5 cc by an intraperitoneal
injection. In Group 3, 10 mg vitamin E diluted in 5 cc olive oil was
injected intraperitoneally. In Group 4, a 2 2 cm human amniotic
membrane was applied to the injured site of the cecum. TheFig. 3. Grade 3 adhesion (More than two bands among visceras).
Table 2













0 – – 3 4 4
1 – – 8 3 5
2 1 2 3 7 6
3 8 11 – – –
4 5 2 – – –
a Human amniotic membrane.
Table 3
Adhesion score of the study groups.
Groups Adhesion score (mean SD)
Group 1 (Control) 3.28 0.61
Group 2 (olive oil) 3.00 0.53
Group 3 (Vit E) 1.00 0.67
Group 4 (HAM) 1.21 0.89
Group 5 (Vit EþHAM) 1.13 0.83
Fig. 4. Grade 1 adhesion (Only one band among visceras).
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the fetal side faced the abdominal cavity. The membrane was
stabilized with two 7/0 polyglactin sutures placed near the
mesenteric part. In Group 5, both human amniotic membrane and
10 mg vitamin E diluted in 5 cc olive oil was applied. The abdominal
incision was closed in two layers with a continuous 3-0 silk suture.
After 15 days all animals were sacriﬁced by an excessive dose of
ether inhalation. The abdominal cavity was inspected, adhesions
were evaluated and all specimens underwent standard histologic
examination.
2.2. Evaluation of adhesion formation
The adhesions were graded by one of the authors, who was
blinded to group assignment. The adhesions were scored using the
classiﬁcation reported by Nair et al.22 (Table 1)
2.3. Histologic examination
Adhesion-carrying tissues were excised en-bloc and ﬁxed in
formaldehyde solution. After dehydration and parafﬁnization,
sections with a thickness of 5 mmwere stained with hematoxylin–
eosin . These cut samples were examined under a light microscope.
Inﬂammation, vascularization and ﬁbrosis in granulation sites were
graded in all samples.23 The accumulation of polymorphonuclear
cells and mononuclear cells reﬂecting inﬂammation was assessed.
Normal cell count was graded 0, slight increase in cells 1, marked
inﬁltration 2, and massive inﬁltration 3. (Fig. 1) Neovascularization
was investigated by scanning of capillary vessel proliferation with
prominent endothelium. In everymiddle power ﬁeld the number of
vessels was evaluated as 0 points if neovascularization was absent,
1 point for 1–2 vessels, 2 points for 3–9 vessels (Fig. 2) and 3 points
for 10 or more vessels. In the assessment of ﬁbrosis the quantitative
increase of young ﬁbroblasts and the presence of collagen were
evaluated together. The scores were between 0 and 3:0 points if
ﬁbrosis was absent, 1 point for slight, 2 point for moderate and 3
point for dense ﬁbrosis and hyalinization. The histopathological
examination of the specimen was performed by a pathologist
blinded to the groups (Figs. 3 and 4).
3. Results
During the study, three animals with early exitus were removed
from the study. One animal from Group 1 and 3 each died duringanesthetic induction, and one animal fromGroup 4 died on the ﬁrst
postoperative day. In macromorphologic evaluation, the distribu-
tion of animals according to adhesions andmean adhesion scores of
the groups are presented in Tables 2 and 3, respectively. The
adhesion scores of Groups 3, 4 and 5 were signiﬁcantly lower
compared to both Group 1 and 2 (p< 0.001).
In pathologic examination, the difference between Group 1 and
2with respect to inﬂammation, neovascularization and ﬁbrosis was
not signiﬁcant. Result of Groups 3, 4 and 5 were signiﬁcantly
different from results of both Group 1 and 2. The difference
between Groups 3, 4 and 5 with respect to these three parameters
was insigniﬁcant. The results of pathological analysis are summa-
rized in Table 4.4. Discussion
Intra-abdominal adhesion formation is initiated by the increase
in vascular permeability and secretion of ﬁbrin-rich exudate which
are triggered by peritoneal injury. Under normal conditions, the
ﬁbrin which has been formed as a result of these reactions
undergoes lysis by the action of peritoneal mesothelial plasmin-
ogen activator. However, these physiologic properties of mesothe-
lial cells are impaired as a result of surgical trauma, ischemia or
inﬂammation. In addition, peritoneal injury results in an increase in
the levels of plasminogen-activator inhibitor-1 and 2, which are
secreted from mesothelial, endothelial, and inﬂammatory cells.
This facilitates adhesion formation by further decreasing plasmin-
ogen-activator activity. In normal conditions ﬁbrinolytic activity is
allowed to occur and ﬁbroblast proliferation results in remesothe-
lization. However under ischaemic conditions present in surgical
trauma, ﬁbrinolytic activity is suppressed and ﬁbrin is allowed to
persist. Once the ﬁbrin bands are inﬁltrated with ﬁbroblasts, they
become organized into adhesions.4,24 Studies that aim to prevent
adhesions have focused on the prevention of various steps of this
physiopathologic process. Antiinﬂammatory agents, antioxidants,
anticoagulants, ﬁbrinolytics,25–27 and bioreabsorbable physical
barriers 28,29 have been used in this regard.
The amniotic membrane hasmany characteristics whichmake it
potentially suitable in the prevention of peritoneal adhesions.
Physical barriers have been used in an attempt to prevent adhesion
formation by limiting tissue opposition during the critical period of
peritoneal healing. This has been shown to take approximately 7
Table 4
Results of the pathologic examinations (mean score SD).
Group1 Control Group 2 Olive oil Group 3 Vit E Group 4 HAMa Group 5 Vit EþHAM
_Inﬂammation 2.2857 0.7263 2.0667 0.5936 1.1429 0.8644 0.8571 0.5345 1.0000 .7559
Fibrosis 2.4286 0.5136 2.2667 0.4577 0.9286 0.7300 1.0667 0.7988 1.1429 0.7703
Neovascularization 2.2143 0.4528 2.0000 0.6547 1.2143 0.8926 1.2667 0.9612 1.0714 0.7300
a Human amniotic membrane.
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day 15, and histologic studies of animals in the amniotic membrane
groups (Groups 4 and 5) revealed that the amniotic membranes
were integrated with the serosal layer and showed neo-
vascularization at the site of the graft (Fig. 5). We believe that the
persistence of the amniotic membrane on the damaged serosal
surface without changing location played an important role in the
signiﬁcantly superior results. Kelekci et al., who investigated the
effect of the amniotic membrane on adhesions stated that in
animals in which the membrane slipped off the damaged surface,
the adhesion scores increased and better results could have been
obtained with by stabilizing the amniotic membrane on the
damaged serosal surface.30 Similarly Young et al. reported that the
amniotic membrane had a slippery structure and recommended
ﬁxing the membrane with on the injured surface with multiple 7/
0 polyglactin sutures. They also reported that while placing the
membrane, the maternal side needs to be placed against injury and
the fetal side facing the abdominal cavity.31 We agree that sutures
are necessary during the placement of the membrane, however
their use should be kept at a minimum since excessive use of
sutures can also trigger adhesion formation. The slippage of the
amniotic membrane was prevented in all animals with two 7/
0 polyglactin sutures placed near the mesenteric aspect. We also
believe that placing the maternal side of the membrane against the
injury is very important; this facilitates healing of the serosal injury
and neovascularization contributes to this healing In contrast to our
opinion, there are studies demonstrating that amniotic membrane
transplanted onto the cornea in vitro and in vivo suppressed neo-
vascularisation.32,33 Regarding the antiangiogenic activity of
human amniotic membrane, pigment epithelium-derived factor
(PEDF), which is localized in the basement membrane, is reported
to play a major role in inhibiting endothelial cell growth in the
cornea.33 In our study, although we observed that neo-
vascularization increased on the maternal side of the amnioticFig. 5. Photomicrograph of serosal surface of cecum covered by amniotic membrane
(HE 40).membrane placed against the injury, histologic evaluation of
adhesions neighboring the fetal side of the amniotic membrane
showed that neovascularization was suppressed signiﬁcantly
compared to the control group. This condition suggested to us that
neovascularization differed according to the location that the
amniotic membrane is applied. Further studies are needed to
address this issue.
Histologic examination of adhesions in animals which under-
went membrane application (Groups 4 and 5) revealed that in
addition to neovascularization, inﬂammation and ﬁbrosis were also
signiﬁcantly lower than the control group. These ﬁndings suggest
that in addition to its properties as a physical barrier, the amniotic
membrane prevents adhesions by inhibition of inﬂammation and
scarring, and regulation of angiogenesis.15–17
Vitamin E presents interesting biological properties and activi-
ties for preventing intraperitoneal adhesions. There are several
reports on the use of vitamin E with variable success for the
prevention of peritoneal adhesions. The oral and intramuscular
administration of vitamin E in the prevention of adhesions has
produced conﬂicting results. Kagoma et al. reported successful
results with the use of oral vitamin E,34 and Cassona et al. reported
that oral vitamin E failed to prevent adhesions.35 Uzunkoy et al.
stated that oral absorbtion of vitamin E ranged between 20 and
60%. The authors therefore recommended intramuscular use of the
vitamin and reported successful results in their experimental
study.36 De La Portilla et al. reported that intramuscular vitamin E
was not sufﬁciently effective in the prevention of adhesions and
adhesions can be signiﬁcantly reduced with intraperitoneal appli-
cation.12 In our study, we found that adhesion scores in the groups
which underwent intraperitoneal vitamin E were signiﬁcantly
lower compared to the control and intraperitoneal olive oil groups.
Another interesting ﬁnding of our study was that intraperitoneal
vitamin E was as effective as amniotic membrane in the prevention
of peritoneal adhesions. These ﬁndings agreewith the results of the
experimental study by Corrales et al.,37 who compared intraperi-
toneal vitamin E with sodium hyaluronate/carboxymethyl cellu-
lose, a bioreabsorbable membrane.
Hemadeh et al. found that oral vitamin E treatment decreased
peritoneal adhesion incidence by 30%, and when intraperitoneal
carboxymethyl cellulose was added to this treatment the incidence
decreased by 90%.21 In this study, simultaneous use of intraperi-
toneal vitamin E and human amniotic membrane, a reabsorbable
physical membrane, did not achieve higher efﬁcacy compared with
the use of vitamin E or amniotic membrane alone.
In conclusion this study showed that intraperitoneal vitamin E
and amniotic membrane treatment were effective in the preven-
tion of peritoneal adhesions. The combination of these two treat-
ments did not create a synergistic effect. The technique of amniotic
membrane application was critical, which made the treatment
difﬁcult. Intraperitoneal vitamin E was equally effective, and easy
applicability was its major advantage.Conﬂicts of interest
None.
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